Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon (original) (raw)

Nature Medicine volume 5, pages 577–581 (1999)Cite this article

Abstract

Most chronic carriers of hepatitis B virus (HBV) do not respond to interferon (IFN) treatment. This limitation of IFN therapy may be due in part to scant expression of IFN receptor in the liver1,2. Because the asialoglycoprotein (ASGP) receptor is specifically expressed in the liver at high density3, the ASGP receptor-binding domain was generated within an N-glycosylated human IFN-β molecule4,5 by the removal of sialic acid to direct this cytokine to the liver. This modified IFN (asialo-IFN-β) demonstrated greater inhibition of HBV production in ASGP receptor-positive human liver cells transfected with a replication-competent HBV construct than did conventional IFN-α or IFN-β. Furthermore, the enhanced antiviral effect of asialo-IFN-β was supported by induction of the 2'-5' oligoadenylate synthetase, an indicator of IFN activity6, at a level significantly higher than that produced by conventional IFN-β. Moreover, mouse asialo-IFN-β profoundly reduced viremia in vivo in HBV-transfected athymic nude mice, in contrast to conventional IFN-β, which had no substantial effect. These experiments demonstrate that directing IFN to ASGP receptor facilitates its signaling in the liver and augments its antiviral effect, and is therefore useful in overcoming the limited antiviral effect of conventional IFNs.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Peska, S. The interferon receptors. Semin. Oncol. 9, S9–18–S9–40 (1997).
    Google Scholar
  2. Rubinstein, M. & Orchansky, P. The interferon receptors. Crit. Rev. Biochem. 21, 249–75 (1986).
    Article CAS Google Scholar
  3. Eisenberg, C. et al. Asialoglycoprotein receptor in human isolated hepatocytes from normal liver and its apparent increase in liver with histological alterations. J. Hepatol. 13, 305–309 (1991).
    Article CAS Google Scholar
  4. Derynck, R. et al. Isolation and structure of a human fibroblast interferon gene. Nature 285, 542–547 (1980).
    Article CAS Google Scholar
  5. Conradt, H.S. et al. Structure of the carbohydrate moiety of human interferon-β secreted by a recombinant chinese hamster ovary cell line. J. Biol. Chem. 262, 14600–14605 ( 1987).
    CAS PubMed Google Scholar
  6. Shindo, M. et al. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B. Hepatology 8, 366–370 (1988).
    Article CAS Google Scholar
  7. Tiollais, P., Pourcel, C. & Dejean, A. The hepatitis B virus. Nature 317, 489–495 (1985).
    Article CAS Google Scholar
  8. Ashwell, G., Harford, J. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem. 51, 531 –554 (1982).
    Article CAS Google Scholar
  9. Wong, D.K.H. et al. Effect of alpha-Interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann. Intern. Med. 119, 312–323 (1993).
    Article CAS Google Scholar
  10. Takahashi, H., Fujimoto, J., Hanada, S. & Isselbacher, K.J. Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc. Natl. Acad. Sci. USA. 92, 1470–1474 (1995).
    Article CAS Google Scholar
  11. Schwartz, A. L., Fridovich, S.E., Knowles, B.B. & Lodish, H.F. Characterization of the asialoglycoprotein receptor in a continuous hepatoma cell line. J. Biol. Chem. 256, 8878– 8881 (1981).
    CAS PubMed Google Scholar
  12. Liang, T.J. et al. Targeted transfection and expression of hepatitis B viral DNA in human hepatoma cells. J. Clin. Invest. 91, 1241–1246 (1993).
    Article CAS Google Scholar
  13. Kawade, Y. An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer. J. Interferon Res. 1, 61–70 (1980).
    Article CAS Google Scholar
  14. Redlich, P.N., Hoeprich, P.D. Jr., Colby, C.B., & Grossberg, S.E. Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping. Proc Natl. Acad. Sci. USA 88, 4040– 4044 (1991).
    Article CAS Google Scholar
  15. Higashi, Y. et al. Structure and expression of a cloned cDNA for mouse interferon-β. J. Biol. Chem. 258, 9522– 9529 (1983).
    CAS PubMed Google Scholar
  16. Karpusas, M. et al. The crystal structure of human interferon β at 2.2-Å resolution. Proc. Natl. Acad. Sci. USA 94, 11813–11818 (1997).
    Article CAS Google Scholar
  17. Lee, Y.C. et al. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J. Biol. Chem. 258, 199–202 ( 1983).
    CAS PubMed Google Scholar
  18. Tartaglia, L.A., Pennica, D. & Goeddel, D.V. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268, 18542–18548 (1993).
    CAS PubMed Google Scholar
  19. Huez, G. Silhol, M. & Lebleu, B. Microinjected interferon does not promote an antiviral response in Hela cells. Biochem. Biophys. Res. Commun. 110, 155–160 (1983).
    Article CAS Google Scholar
  20. Branca, A.A., Faltynek, C.R., D'Alessandro, S.B. & Baglioni, C. Interaction of interferon with cellular receptors. Internalization and degradation of cell-bound interferon. J. Biol. Chem. 257, 13291–13296 (1982).
    CAS PubMed Google Scholar
  21. Seif, I., De Maeyer, E., Riviere, I. & De Maeyer-Guignard, J. Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment. J. Virol. 65, 664–671 ( 1991).
    CAS PubMed PubMed Central Google Scholar
  22. Killion, J.J. et al. Augmentation of antiproliferative activity of interferon alfa against human bladder tumor cell lines by encapsulation of interferon alfa within liposomes. J. Natl. Cancer Inst. 81, 1387–1392 (1989).
    Article CAS Google Scholar
  23. Burgess, J.B., Baenziger, J.U., Brown, W.R. Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 15, 702 –706 (1992).
    Article CAS Google Scholar
  24. Hyodo, I., Mizuno, M., Yamada, G. & Tsuji, T. Distribution of asialoglycoprotein receptor in human hepatocellular carcinoma. Liver 13, 80–85 ( 1993).
    Article CAS Google Scholar
  25. Trubetskoy, V.S., Torchilin, V.P., Kennel, S. & Huang, L. Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(L-lysine)-antibody conjugate in mouse lung endothelial cells. Biochim. Biophys. Acta 1131 , 311–313 (1992).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank S. Goelz (Biogen) and S. Yamazaki (Toray Industries) for the preparations of mouse and human IFN-βs; V. Trubetskoy and V. Torchilin for the preparation of in vivo transfection reagents; D. Frederick for technical assistance; T. Takehara, J.L. Dienstag and D.K. Podolsky for critical review of this manuscript; and H. Tsubouchi for support of T.E. This work was supported by Grants CA57584 and NIDDK4331 from the National Institutes of Health and an Educational Grant from Toray Industries.

Author information

Authors and Affiliations

  1. Gastrointestinal Unit, Harvard Medical School and Massachusetts General Hospital, Jackson 7, Fruit St., Boston , 02114, Massachusetts, USA
    Toshiharu Eto & Hiroshi Takahashi

Authors

  1. Toshiharu Eto
    You can also search for this author inPubMed Google Scholar
  2. Hiroshi Takahashi
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toHiroshi Takahashi.

Rights and permissions

About this article

Cite this article

Eto, T., Takahashi, H. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon.Nat Med 5, 577–581 (1999). https://doi.org/10.1038/8462

Download citation